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Posterior circulation strokes represent approximately 20% of all ischemic strokes (1, 2).
In contrast to the anterior circulation, several differences in presenting symptoms, clini-
cal evaluation, diagnostic testing, and management strategy exist presenting a challenge
to the treating physician. This review will discuss the anatomical, etiological, and clinical
classification of PC strokes, identify diagnostic pitfalls, and overview current therapeutic
regimens.
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DEFINING THE POSTERIOR CIRCULATION
A posterior circulation (PC) stroke is classically defined by infarc-
tion occurring within the vascular territory supplied by the verte-
brobasilar (VB) arterial system. The vertebral arteries (VAs) arise
from the right and left subclavian arteries and travel cranially
through the transverse foramina of the cervical vertebrae. When
reaching the foramen magnum, they pierce the dura mater to start
their intracranial course. Both VAs join at the pontomedullary
junction forming the basilar artery (BA). The VAs are divided into
four segments.V1 is the most proximal segment from theVA origin
to point of entry into the initial foramen transversarium, usually at
the sixth or seventh cervical vertebral body. The segment occupy-
ing the course of the VA from the initial to last transverse foramen
is known as V2. The V3 segment begins after the artery exits the
foramen transversarium of the axis (C2) and arches behind the
atlas (C1) before entering the cranium. The most distal segment
representing the intracranial portion of the VA after entering the
dura mater is the V4 segment. The BA travels rostral along the ven-
tral medulla and basis pontis until it bifurcates into the right and
left posterior cerebral arteries (PCAs) at the pontomesencephalic
junction. Segments of the vertebral artery and branches of the
vertebrobasilar system are depicted in Figure 1. The topographic
classification described by Caplan in the New England Medical
Center-posterior circulation registry (NEMC-PCR) (3) divides
the intracranial vertebrobasilar system into proximal, middle, and
distal territories.
ANATOMICAL VARIANTS OF THE POSTERIOR CIRCULATION
AND CLINICAL SIGNIFICANCE
Anatomical variations of the PC are frequent but commonly
asymptomatic. Familiarity with these variants is important as
not to mistake them as pathological findings. Although typically
discovered incidentally, they are infrequently related to intracra-
nial vascular pathology.
Asymmetric VAs occur in over two-thirds of individuals (4, 5)
(Figure 2A) and an incomplete circle of Willis (COW) may be
seen in over half (6) (Figure 2B). A persistent trigeminal artery is
the most common carotid–vertebrobasilar anastomosis (7). Other
intracranial anomalies include fenestration of the vertebrobasilar
junction (0.3–0.6%) which may predispose to PC aneurysm for-
mation (8) (Figure 2C), persistent hypoglossal artery, the artery of
Percheron, fetal origin of one or both PCAs (fPCA) (Figure 2D),
and absence of one or both posterior communicating arteries
(PCOMs) (Figure 2B). The labyrinthine artery usually arises from
the anterior inferior cerebellar artery (AICA); however this vessel
may arise directly from the BA. Pertinent anatomical variants and
their clinical significance are highlighted.
ARTERY OF PERCHERON
The artery of Percheron is where a single thalamic perforating artery
arises from the proximal PCA (P1 segment) between the BA and
PCOM and supplies the rostral mesencephalon and both para-
median thalami (9, 10). Proximal embolism is thought to be the
most common etiology of stroke in this territory with this variant
(9–11).
Asymmetric thalamic involvement is seen in two-thirds of cases
and midbrain infarction is present in over half (9, 10). Patients with
bilateral paramedian thalamic lesions may develop altered senso-
rium, vertical gaze palsy, and memory impairment (10). Conven-
tional vascular imaging does not routinely demonstrate these tiny
perforating vessels. Hypoplastic or absent P1 segments are more
likely to be seen with this variant (11). Other vascular causes of
bilateral thalamic injury include venous thrombosis (12), top of
the basilar occlusion (13), and hypoxic–ischemic injury (14).
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FIGURE 1 | Vertebrobasilar system. PCA, posterior cerebral artery; SCA,
superior cerebral artery; BA, basilar artery; AICA, anterior inferior cerebellar
artery; PICA, posterior inferior cerebellar artery; V1–V4, segments of the
vertebral artery. Proximal territory, areas supplied by the intracranial VAs and
PICAs up to the VB junction; middle territory, BA and AICAs up to the SCAs;
distal territory, rostral BA, SCAs, and PCAs.
INCOMPLETE CIRCLE OF WILLIS AND THE FETAL PCA
An incomplete COW is present in 48–58% of the population (6)
(Figure 2B). A PCA arising directly from the intracranial internal
carotid artery (ICA) is defined as fPCA and most are unilateral
(Figure 2D). A fPCA is either partial or complete depending on
whether or not a hypoplastic P1 segment is present and occurs
in 10–29% of the population (6, 15) (Figure 2C). Bilateral fPCAs
are associated with a small caliber BA, as the BA does not con-
tribute to mesencephalic, temporal, or occipital lobe flow. There
is no established association between unilateral or bilateral fPCAs
and stroke risk (15, 16). On the other hand, the etiologic eval-
uation of occipital stroke in patients with an ipsilateral fPCA
should include an assessment for carotid artery disease. More-
over, patients with hemodynamically significant carotid occlusive
disease and ipsilateral fPCAs lack the capacity to develop lep-
tomeningeal anastomoses between the anterior cerebral artery
(ACA), middle cerebral artery (MCA), and PCA. Patients with ICA
occlusion, an ipsilateral fPCA, and a non-functioning ACOM may
be particularly vulnerable to ischemia and infarction due to hemo-
dynamic failure compared to those with adequate contralateral
flow through a functioning ACOM (17).
ANATOMICAL VARIATIONS OF THE VERTEBRAL ARTERIES
Approximately 70% of people have a left dominant VA (4, 5)
(Figure 2A). In some, the non-dominant hypoplastic VA con-
genitally ends in the posterior inferior cerebellar artery (PICA)
without joining the BA. VA hypoplasia (VAH) has been associated
with PC stroke (5, 18). In a study evaluating the correlation of VA
asymmetry and pontine infarctions, patients with VA asymmetry
(defined as internal vessel diameter ratio of 1:2 or more) had twice
as many pontine infarctions than those with symmetric VAs. The
infarcts more commonly occurred ipsilateral to the smaller ves-
sel (18). Another study reporting VAH in 13% of patients with
PC strokes found this variant to be more common in PC strokes
as compared to matched controls with AC strokes. Moreover, the
majority of PC strokes affected the brainstem and cerebellum (5).
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FIGURE 2 | (A) Hypoplastic right vertebral artery (bottom arrow);
basilar artery displacement opposite to the dominant vertebral artery
(top arrow); (B) incomplete circle of Willis, absent left posterior
communicating artery (bottom arrow), absent left A1 segment (top
arrow); (C) fenestration of the basilar artery (bottom arrow);
hypoplastic right P1 segment (top arrow) and (D) posterior cerebral
artery arising directly from the internal carotid artery (fetal variant,
arrow).
Basilar artery curvature may result from congenital asymmet-
ric blood flow to the VB junction causing asymmetric vessel wall
tension, displacement, and elongation of the BA (Figure 2A). The
resulting inner wall shear stress may cause endothelial injury lead-
ing to local thrombosis, torsion of the pontine perforating arteries,
or diminished blood flow in the smaller intracranial VA leading to
subsequent pre- and post-junction infarctions (4).
The relationship between VAH, BA curvature, and stroke lat-
erality has been evaluated. In one study, 69% of patients with
pontine or PICA territory infarctions had VAH and 75% had BA
displacement opposite to the dominant VA. Pontine infarction
occurred contralateral to the side of the BA displacement in 72%
of patients. PICA territory infarction was seen ipsilateral to the
VAH in 72% (Figure 3A). In addition, greater difference in VA
diameters predicted more severe BA curvature (4).
ETIOLOGIES OF ISCHEMIC POSTERIOR CIRCULATION STROKE
Beyond the minority of cases associated with vascular anom-
alies of the PC previously discussed, several pathological and
demographic differences must be considered when determining
stroke etiology. Multiple stroke registries have been analyzed to
investigate the patient characteristics and most common etiologies
of PC stroke.
ATHEROSCLEROSIS
Large vessel atherosclerotic disease within the PC can result in
thromboembolism, or less commonly, hemodynamic failure lead-
ing to ischemia (19). A study of combined registries found large
vessel atherosclerotic disease to be responsible for 35% of PC
strokes and small vessel disease accounting for 13% (2). The most
common locations of VA atherostenosis are the V1 and V4 segment
(3, 20). Caucasian men more commonly have extracranial ather-
osclerosis and evidence of concomitant coronary and peripheral
vascular disease (21). Alternate pathology, such as arterial dissec-
tion, should be considered when stenosis only involves the V2 and
V3 segments. Arterial wall fatty streaks, fibrous plaques, and calci-
fied plaques are less prevalent in the VA as compared to the carotid
artery (20).
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FIGURE 3 | (A) MRI fluid-attenuated inversion recovery (FLAIR)
sequence showing a right lateral medullary infarction in a 32-year-old
woman with a hypoplastic right vertebral artery shown in Figure 2A;
(B) catheter angiogram of a 55-year-old African-American man showing
atherostenosis at the vertebrobasilar junction (arrow); (C) non-contrast
CT showing a left posterior cerebral artery territory infarction in a
60-year-old man with atrial fibrillation; (D) catheter angiogram showing a
right distal vertebral dissecting aneurysm with intraluminal thrombus
(arrow) in a 19-year-old man presenting with vertigo, ataxia, and a right
cerebellar infarction.
Steno-occlusive atherosclerotic disease as an embolic source
most commonly affects the PICA territory, distal BA, superior
cerebellar artery (SCA), and PCA branches (22). AC strokes related
to cervical ICA stenosis are associated with thrombogenic plaque
characteristics (23). Similarly, lesion irregularity and plaque mor-
phology correlate with severity of ischemic presentation in the
PC (24).
The most common intracranial site of atherostenosis is the BA,
followed by the ICAs, MCAs, VAs, PCAs, and ACAs. Intracranial
stenosis is more prevalent among African-American and Asian
individuals and may account for a higher rate of strokes in these
populations compared to Caucasians (Figure 3B). Neurovascular
imaging techniques such as endovascular ultrasound and high res-
olution MRI have shown both vulnerable atherosclerotic plaques
and fibroproliferative lesions (25).
Ischemia due to intracranial disease may result from tis-
sue hypoperfusion, in situ thrombosis, or artery-to-artery
thromboembolism. Mild intracranial disease may have minimal
effect on cerebral hemodynamics. As the stenosis increases, reflex
vasodilation due to inadequate or failing collateral circulation
occurs to increase cerebral blood volume (CBV) and preserve nor-
mal cerebral blood flow (CBF), and oxygen extraction fraction will
increase as CBF further deteriorates. Failure of these compensatory
mechanisms is known as “misery perfusion” (26). Patients with
tandem extracranial and intracranial lesions or bilateral disease
more commonly suffer clinical effects of hemodynamic changes
(3, 24). “Tandem lesions” are commonly found in patients with
VA atherosclerosis and PC stroke (22).
CARDIOEMBOLISM
Approximately 40% of cerebral blood flow goes to each ICA and
only 20% goes to the PC. Therefore by chance, a fifth of cardiac
emboli may end up within the PC (3). Cardiac diseases with risk for
embolism include mechanical prosthetic valves, atrial fibrillation,
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left atrial or ventricular thrombus, myocardial infarction within
4 weeks of stroke, dilated cardiomyopathy, infective endocarditis,
mitral stenosis without atrial fibrillation, bio-prosthetic cardiac
valves, and congestive heart failure (Figure 3C).
In 407 patients in the NEMC-PCR, embolism (cardiac, artery-
to-artery, or both) was the most common etiology (40%) and
a cardiac source of embolism was reported in 24%. Distal PC
territory infarctions were most common followed by the mid-
dle territory (3). In contrast, the Hallym stroke registry (HSR)
reported large artery stenosis in nearly half of 591 Korean patients
with PC strokes, intrinsic small vessel disease in a third, and only
11% had potential cardiac sources of embolism. Middle territory
infarction occurred in 36.5% of patients followed by the distal
territory in 28.1% (27).
VARIATIONS IN PC STROKE ETIOLOGY
Similarities and differences in both registries exist. The preva-
lence of hypertension, diabetes, hyperlipidemia, and smoking were
similar in both registries. Over 80% of both cohorts were inves-
tigated with magnetic resonance imaging (MRI) and magnetic
resonance angiography (MRA). Compared to HSR, the NEMC-
PCR included a higher proportion of men (63 vs. 56%) and
patients were slightly younger (mean age 61 vs. 63 years). NEMC-
PCR patients were predominantly Caucasian (84%) and only a
minority was Asian (9.5%) (3).
In the HSR, cardiac risk factors were found less frequently com-
pared to the NEMC-PCR. Transthoracic echocardiography (TTE)
was only performed in 37.5%, transesophageal echocardiography
(TEE) in 14.1% in contrast to the NEMC-PCR, and VA origins
were not routinely evaluated (27). The lower cardioembolic risk
of the HSR may have accounted for fewer infarctions in the dis-
tal and multiple territories compared to the NEMC-PCR (25, 28).
A higher prevalence of intracranial atherosclerotic disease in the
Korean population may have accounted for a higher proportion
of middle territory infarctions.
VERTEBROBASILAR DOLICHOECTASIA
Vertebrobasilar dolichoectasia (VBD) refers to dilatation, elonga-
tion, and tortuosity of the BA. The anatomy is highly variable.
Asymptomatic patients may be found to have VBD incidentally
on neuroimaging while other patients present with vertebrobasilar
territory ischemia (29). Risk factors for VBD include male gender,
increasing age, hypertension, smoking, and history of a myocardial
infarction. VBD has been associated with aortic dilations, ectatic
coronary arteries, Marfan syndrome, late-onset Pompe disease,
autosomal dominant polycystic kidney disease, and Fabry dis-
ease (30). The estimated 5-year complications in VBD is 17.6%
for ischemic stroke, 10.3% for brainstem compression, 10.1%
for TIAs, 4.7% for hemorrhagic stroke, 3.3% for hydrocephalus,
and 2.6% for subarachnoid hemorrhage (SAH) (30). Long-term
prognosis may be related to VBD severity and evolutionary char-
acteristics such as vertical elongation, lateral displacement, and
diametric changes over time (29).
ARTERIAL DISSECTION
Cervical artery dissections (CADs) may occur spontaneously or
result from major or minor cervical trauma (31). In young adults
(15–49 years), CADs accounts for approximately 15% of strokes
(32, 33). The presence of headache, neck pain, history of trauma,
or neck manipulation associated with stroke should raise suspi-
cion (34). VA dissections are most commonly found in the V2 and
V3 segments (35). Posterior neck pain is present in half of patients
and headache (more commonly occipital) occurs in two-thirds.
In addition, VA dissections more frequently present with ischemia
(>90%) and PICA territory strokes (lateral medullary and/or cere-
bellar) are common (36). Isolated neck pain or headache without
ischemic symptoms can be observed in 12% (35). Compared to
patients with ICA dissections, patients are younger, more com-
monly have neck pain, are more likely to have associated SAH, and
take 2 days longer on average to diagnose (37, 38). Approximately
10% of VA dissections extend intracranial (35). Intracranial exten-
sion carries a higher risk of dissecting aneurysm formation, SAH,
and mortality (39) (Figure 3D).
OTHER ETIOLOGIES AND ASSOCIATIONS
Other less common causes of ischemia with predilection for the PC
circulation include subclavian steal syndrome, giant-cell arteritis,
and Fabry disease. Mitochondrial encephalopathy, lactic acido-
sis, and stroke like episodes (MELAS), migraines, and posterior
reversible encephalopathy syndrome (PRES) also have a predilec-
tion for the PC (19). Reversible cerebral vasoconstriction syn-
drome (RCVS) should be considered in the differential diagnosis
of sudden onset headache and focal neurological deficits as this
may mimic PCA embolus presentation (40).
CLINICAL PRESENTATIONS OF POSTERIOR CIRCULATION
STROKE
In clinical practice, not all PC stroke presentations are classic.
Many patients present with signs and symptoms of multifocal PC
infarctions. Moreover, the PC is rich in potential collateral support
and clinical manifestations of BA ischemia may be highly variable.
Symptoms associated with PC strokes such as diplopia, visual field
defects, dysphagia, vertigo, alteration in consciousness, or hear-
ing loss may aid with localization. PC strokes have fewer cortical
findings and relatively small lesions can cause significant deficits
as compared to AC stroke due to the close proximity of major
afferent and efferent tracts and cranial nerve nuclei in the brain-
stem. Table 1 lists vascular territories of the PC with corresponding
clinical findings and classic stroke syndromes.
COMMON SYMPTOMS OF POSTERIOR CIRCULATION STROKE
Common presenting symptoms of PC stroke include vertigo,
imbalance, unilateral limb weakness, slurred speech, double vision,
headache, nausea, and vomiting. Exam findings include unilateral
limb weakness, gait ataxia, limb ataxia, dysarthria, and nystagmus.
Infarcts involving the proximal PC territory may cause dyspha-
gia due to pharyngeal weakness, nausea, vomiting, and Horner’s
syndrome. Infarcts involving the middle territory are often asso-
ciated with limb weakness and nuclear facial palsy. Distal territory
infarctions are commonly associated with decreased appendicu-
lar sensory loss, lethargy, and visual field defects (41). Patients
typically present with more than one finding and rarely have an
isolated symptom or sign of PC ischemia (21). The frequency of
common presenting signs and symptoms of PC infarcts from the
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Table 1 | Vascular territories of the PC with corresponding clinical findings.
Vascular territory Anatomical location Stroke syndrome Clinical findings
Unilateral PCA Occipital lobe Contralateral homonymous
hemianopsia
Homonymous hemianopsia with macular sparing
Dominant occipital lobe plus
splenium of corpus callosum
Alexia without agraphia Homonymous hemianopsia and alexia without
agraphia
Ventral occipital cortex;
infracalcarine
Achromatopsia Loss of color differentiation contralateral to the side
of the lesion, can be associated with a
quadrantanopsia
Optic radiation Inferior quadrantanopsia Inferior quadrantanopsia
OR supracalcarine
Myers loop (temporal lobe) or
infracalcarine
Superior quadrantanopsia Superior quadrantanopsia
Bilateral PCA Both occipital lobes Cortical blindness Bilateral cortical blindness with normal
ophthalmological findings
Anton’s syndrome Cortical blindness with denial of blindness and
confabulations or visual hallucinations
PCA–MCA border
zone regions
Bilateral ventral–mesial
occipital–temporal border zones
Prosopagnosia Inability to recognize familiar faces and/or interpret
facial expressions. Retained ability to identify with
speech or unique feature (e.g., glasses, facial hair,
tattoo, etc.)
Bilateral occipital–parietal border
zones
Balint’s syndrome Optic ataxia (inability to reach targets with visual
guidance), oculomotor apraxia (inability to
volitionally direct gaze), and simultagnosia (inability
to synthesize objects within a visual field)
Unilateral left temporal–parietal
border zone
Transcortical sensory aphasia Impaired comprehension, fluent speech but
preserved repetition
PICA Inferior posterior cerebellar
hemisphere, inferior vermis,
lateral medulla
Lateral medullary or Wallenberg
syndrome
Superior cerebellar artery
syndrome
Vertigo, nausea, vomiting, ipsilateral facial
numbness and dysmetria, Horner’s syndrome,
dysphagia, and ataxia dysphonia contralateral
hemisensory loss below the face
SCA Dorsolateral upper brainstem
and cerebellum and superior
cerebellar peduncle
Superior cerebellar artery syndrome Ipsilateral limb ataxia, vertigo, nystagmus,
dysarthria, and gait ataxia
AICA Ipsilateral labyrinth, lateral
pontine tegmentum, and
brachium pontis, ICP
Lateral pontine syndrome Ipsilateral dysmetria, hearing loss, Horner’s
syndrome, choreiform dyskinesia, contralateral
thermoanalgesia
Top of the BA Midbrain, thalamus, and mesial
temporal lobes and occipital
lobes
Top of the basilar syndrome Somnolence, peduncular hallucinosis, convergence
nystagmus, skew deviation, oscillatory eye
movements, Colliers sign (retraction and elevation
of eye lids), vertical gaze paralysis
Mid-BA Lateral and medial pons Lateral mid-pontine syndrome Ipsilateral loss of facial sensation and motor
function of the trigeminal nerve, ipsilateral
dysmetria
Medial mid-pontine syndrome Ipsilateral dysmetria, contralateral arm and leg
weakness and gaze deviation
Pontine paramedian
penetrators
Anteromedial pons Dorsal mid-pontine syndrome Ipsilateral nuclear facial palsy, horizontal gaze palsy,
and contralateral arm and leg weakness
(Continued)
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Table 1 | Continued
Vascular territory Anatomical location Stroke syndrome Clinical findings
Short pontine
circumferential arteries
Anterolateral pons Superior medial pontine syndrome Ipsilateral intranuclear ophthalmoplegia, palatal,
facial, pharyngeal and/or ocular myoclonus,
dysmetria, and contralateral arm and leg
weakness, ocular bobbing
Proximal BA Lower pons Locked-in syndrome Quadriplegia, horizontal gaze paralysis, bifacial,
paralysis, and tongue and mandibular weakness.
Awareness is spared
VA Medulla and cervical spinal cord Medial medullary or Dejerine
syndrome (intracranial disease may
lead to Wallenberg syndrome)
Contralateral arm and leg weakness, hemibody
loss of tactile, vibration, position sense, ipsilateral
tongue paralysis
Anterior spinal artery Anterior spinal artery syndrome Quadriparesis, bilateral pain and temperature loss,
decreased sphincter tone, autonomic instability,
and hyperreflexia. Proprioception spared
Table 2 | Frequency of common presenting signs and symptoms of
posterior circulation infarcts.
Symptoms and signs NEMC-PCR
(n=407) (%)
IPCSQ
(n=116) (%)
Dizziness or vertigo 47 75
Dysarthria 31 64
Nausea or vomiting 27 60
Loss or alteration of consciousness 5 18
Limb weakness 38 49
Ataxia 31 65
Nystagmus 24 48
NEMC-PCR, New England Medical Center posterior circulation registry; IPCSQ,
ischemic posterior circulation stroke in State of Qatar.
NEMC-PCR (41) and ischemic posterior circulation stroke in state
of Qatar registry (IPCSQ) (42) are summarized in Table 2.
NATURAL HISTORY OF POSTERIOR CIRCULATION ISCHEMIA
Typical of stroke, symptoms are sudden and maximal at onset. Ver-
tebrobasilar insufficiency (VBI) refers to PC symptomatology due
to hemodynamic failure resulting in ischemia. A steno-occlusive
lesion at any level due of the VA due to any cause may lead to VBI
and a physical examination alone is insufficient for diagnosis (43).
A detailed clinical history, evaluation of traditional risk factors,
and thorough examination in patients with VB symptomatology
is paramount.
Vertebrobasilar TIA may precede PC stroke in approximately
one-fourth of cases (3). Episodes of diplopia, vertically oriented
binocular visual field loss, vertigo, ataxia, impaired sensorium, or
“crossed-findings” (ipsilateral cranial nerve deficits and contralat-
eral long tract signs) are localizing. History of neck pain, trauma,
or headache particularly in younger patients may suggest verte-
bral dissection. Fleeting or stuttering vertebrobasilar symptoms
are concerning and should prompt evaluation of basilar artery
patency. Distal and mid-basilar artery occlusions typically result
in abrupt events without prodromal signs or symptoms as com-
pared to proximal lesions where a fluctuating and progressive
course is observed (44). Fluctuating symptoms in the setting of
a patent basilar artery was described by Saposnik and colleagues
as the “pontine warning syndrome” and characterized by episodes
of motor or sensory dysfunction, dysarthria, or ophthalmoplegia
due to basilar branch artery disease leading to ventral pontine
infarctions (45) (Figure 4A).
History of unilateral arm pain with exertion associated with
VBI symptomatology may suggest proximal subclavian artery
stenosis causing reversal of normal flow within the ipsilateral ver-
tebral and basilar arteries, known as the subclavian steal syndrome
(46). A blood-pressure differential (BPD) of>20 mm Hg between
both arm measurements aids in identifying patients with subcla-
vian stenosis (47), however two-thirds of patients with subclavian
steal may be asymptomatic. Symptomatic patients commonly have
concomitant carotid disease which may provoke VB symptoms
(46). Patients with a higher BPD measurement (>40–50 mm Hg)
and complete steal phenomenon would more likely benefit from
intervention (47).
Vertebrobasilar symptoms or syncope with head-turning
known as rotational vertebrobasilar insufficiency or bow hunter’s
syndrome is rare. This is most commonly caused by compression
of the vertebral artery due to cervical bony osteophyte in older
patients, C1–C2 hypermobility, or even neck muscle hypertrophy
in younger patients (48, 49).
NON-SPECIFIC SYMPTOMS OF POSTERIOR CIRCULATION
ISCHEMIA
DIZZINESS AND VERTIGO
Dizziness, albeit descriptive, is a non-specific term that is com-
monly used interchangeably with vertigo by patients. Moreover,
patients commonly use dizziness to describe feeling faint or light-
headed. Nearly 7.5 million patient visits per year in the ambulatory
setting are due to dizziness as the presenting symptom (50, 51). In
a study of 1666 patients presenting to the emergency department
with complaints of dizziness, vertigo, or imbalance; stroke or TIA
was diagnosed in only 3.2% (33 ischemic strokes, 17 TIAs, 1 ICH,
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FIGURE 4 | (A) MRI diffusion-weighted image (DWI) demonstrating a
right ventral pontine infarction (arrow) in a 62-year-old man with
fluctuating left sided weakness; (B) MRI-DWI showing a small dorsal
left medullary infarction (arrow) in a 58-year-old man with
hypertension and hyperlipidemia presenting with acute isolated
vertigo; (C) catheter angiogram showing cut-off of the right posterior
inferior cerebellar artery (arrow); (D,E) MRI-DWI showing massive
right cerebellar hemispheric and vermian infarction; (F) MRI
T2-weighted sequence demonstrating right cerebellar infarction with
edema and mass effect.
and 2 undetermined) (51). Patients with cerebrovascular events
were older and more likely to have two or more stroke risk factors
than those with other etiologies of their symptoms.
In contrast, in 240 patients clinically diagnosed with vestibu-
lar neuritis due to vertigo lasting >24 h without accompanying
neurological symptoms and a normal neurologic examination,
cerebellar infarctions were found in 10% of patients. Almost all
infarctions were within the PICA territory (52). However, only
17% of patients with PICA territory strokes presented with signs
and symptoms consistent with vestibular neuritis. The inves-
tigators termed this phenomenon, “pseudo-vestibular neuritis.”
These findings underscore the non-specific nature of these symp-
toms, need for careful clinical assessment, and importance for
appropriate imaging consideration (Figure 4B).
Qualitative descriptions may be less dependable than estimates
of the duration and situations that preceded or provoked the event
(53). Brief, vertiginous episodes that occur frequently and begin
soon after head movement are more consistent with benign posi-
tional vertigo than ischemia (50, 53). Symptoms that increase in
frequency or severity should raise more concern (54). Central
vertigo may or may not be exacerbated by head positioning. When
central vertigo occurs after head positioning, there is usually no
latency unlike the latency seen with benign paroxysmal positional
vertigo as an otoconial particle travels within the endolymph of
the semicircular canals.
Ischemia associated with vertigo is often accompanied by other
brainstem or cerebellar signs and symptoms (53). Provocative
maneuvers such as the head thrust and Dix–Hallpike maneuvers
can help differentiate between central and peripheral etiologies. In
the Dix–Hallpike maneuver, patients whose symptoms are repro-
duced in the supine position with the head tilted down and rotated
after 5–10 s latency with or without observable rotational nystag-
mus are likely to have a peripheral etiology (50). Symptoms and
nystagmus that occur immediately upon positioning may occur
with both peripheral and central etiologies. Patients that exhibit a
corrective saccade after a head thrust in the direction of the dys-
functional side with eyes fixed invariably have peripheral vertigo
(52, 54). In contrast, none of the patients with “pseudo-vestibular
neuritis” due to a PICA territory infarction in the aforementioned
study had a positive head thrust test. Peripheral vertigo may be
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associated with tinnitus or hearing loss (50) and typically does
not present with pupillary abnormalities, dysconjugate gaze, dys-
metria, motor weakness, or depressed level of consciousness. The
presence of any of these suggests a central etiology. Vertical nystag-
mus and direction-changing nystagmus are also specific for central
lesions.
In patients presenting with acute vestibular symptoms (vertigo,
nausea, vomiting, head motion intolerance, and/or nystagmus),
the HINTS method, a three-step bedside evaluation composed of
horizontal head impulse testing, nystagmus evaluation, and testing
of skew can be easily performed in about 1 min. A negative (nor-
mal) head impulse, alternating nystagmus, and presence of skew
(refixation on cover–uncover testing) has a sensitivity and speci-
ficity of 100 and 96%, respectively, for detecting stroke. In addition,
the presence of skew deviation is highly specific for brain stem
dysfunction in patients with the aforementioned symptoms (55).
ATAXIA
Gait ataxia may be central, vestibular, or sensory in origin. It is
almost always present in PC stroke involving the brainstem and
cerebellum (56) and nearly all patients with cerebellar ataxia fall
toward the lesion side (57). When stratified by infarction site, the
frequency of gait ataxia is similar across all territories but tends
to be most severe when the cerebellum and cerebellar tracts of
the brainstem are involved (56). Furthermore, ataxia associated
with a central lesion tends to begin abruptly with full severity
at onset (58). Lack of gait evaluation and coordination testing
in patients with ataxic symptoms is a common cause of misdi-
agnosis of cerebellar infarction (59). Dysmetria assessment with
finger–nose–finger or heel-to-shin testing and clumsiness with
rapid alternating movements (i.e., dysdiadochokinesia) may help
evaluate cerebellar dysfunction (50).
HEADACHE
Headaches occur commonly in the general population due to myr-
iad etiologies and are non-specific symptoms in many cases. The
frequency of headache with stroke is approximately 27%, and
increases to 46–70% when the PC is involved (60). Headaches
associated with PC territory infarcts may be due to irritation of
trigeminovascular afferents densely located in brainstem arteries
(60). Patients with cerebellar infarcts and unilateral headaches
typically have lesions in the ipsilateral cerebellum (57). Table 3
summarizes differentiating features of peripheral and central orig-
inated vertigo, nystagmus, ataxia, headache, as well as test finding
differences.
NEUROIMAGING IN PC STROKE
Brain computed tomography (CT) is typically performed as the
initial imaging modality for patients presenting with acute stroke
symptoms. Unfortunately, CT provides suboptimal visualization
of the posterior fossa structures due to obscuration by artifacts
produced by the bony structures of the cranial base and early
ischemic changes may not be visible. In contrast, MRI provides
better visualization of the soft tissue structures (61) and is superior
for detecting early evidence of infarction with diffusion-weighted
imaging (DWI) sequences. However, in the acute setting, MRI
is more time consuming and in patients with metallic foreign
Table 3 | Differentiating features of peripheral and central originated
vertigo, nystagmus, ataxia, and headache.
Summary of peripheral vs. central etiology distinguishing features
Peripheral cause Central cause
VERTIGO
Onset Acute or gradual Acute
Duration Minutes to hours Days to weeks
Impact of head
movement
Worsens Variable
Auditory symptoms Frequent Often absent
Dix–Hallpike Positive Negative
Associated neurological
findings
Absent Often present
NYSTAGMUS
Direction of fast-phase Unidirectional Can be alternating
Vertical component Absent Can be present
Fatigability Fatigable in 30–60 s Not fatigable
Presence of vertigo
symptoms
Always present Can be absent
ATAXIA
Gait ataxia Present but less severe Very severe
Truncal ataxia Uncommon Common
Cerebellar testing Normal Frequently abnormal
Onset Acute or gradual Acute
Severity at onset Less likely to be severe
at onset
More likely to be
maximal at onset
Headache Uncommon Common
Location Variable Occipital
Unilateral Variable Commonly unilateral
Onset timing Variable Typically at time of other
symptoms
HINTS
Head impulse test Abnormal (gaze
correction)
Normal
Nystagmus Fast-phase in one
direction
Fast-phase alternating
directions
Test of skew Skew absent Skew present
bodies, incompatible pacemakers, or claustrophobia it cannot be
performed safely.
Subtle hypodensities, loss of gray–white matter differentiation
and sulcal effacement have been used to asses for signs of early
ischemia on non-contrast head CT. The Alberta Stroke Program
Early CT Score (ASPECTS) provides a reliable and standardized
topographic assessment of acute ischemic changes in the MCA
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territory with predictive value (62, 63). In contrast, early ischemic
signs on CT in the PC are not as well-established (64). This may
be in part due to the smaller area interpreted and density of the
posterior fossa. The Posterior Circulation Acute Stroke Progno-
sis Early CT Score (pc-ASPECTS) has been proposed (65). This
score is more sensitive for detection of early ischemic change
and prediction of functional outcomes with contrast infusion (as
compared to non-contrast CT), and could help identify patients
with BA occlusion who are unlikely to have favorable outcomes
despite recanalization (65). Infarction size in the PC does not cor-
relate well with stroke severity (66). Due to the close proximity of
vital tracts and nuclei, location site is a more critical functional
outcome predictor (67). Applying the pc-ASPECTS score to MRI-
DWI has been shown to be a powerful marker for the prediction
of functional outcome of PC stroke (68).
Despite the superior sensitivity of MRI-DWI in detection of PC
stroke compared to CT, MRI can rarely be negative for small infarc-
tions (19). In one study, DWI imaging was falsely negative in 5.8%
of all patients with stroke symptoms lasting >24 h when imaging
was obtained within 48 h of onset. The false-negative DWI rate
for PC stroke was almost 10 times higher than that of the AC (19
vs. 2%). Moreover, up to a third of patients in that study present-
ing with vertebrobasilar ischemic symptoms who had an initial
false-negative DWI study during the first 24 h had positive stud-
ies on follow-up (69). Similarly, a 12% false-negative DWI rate
was reported for patients with acute vestibular symptoms and PC
stroke, when imaging was done within 48 h of symptom onset (55).
These studies highlight the importance of adequate history taking,
thorough neurologic examination, and a high index of suspicion
during patient evaluation beyond sole reliance on neuroimaging.
Presence of a hyperdense BA sign in the setting of acute PC
stroke may be indicative of thrombosis. This finding has been
shown to be 71% sensitive, 98% specific, and 94% accurate for
BA occlusion with a positive predictive value of 83%, negative
predictive value of 95%, and a strong predictor of short- and
long-term outcome (70). The gold standard for intracranial and
extracranial vascular imaging remains the conventional catheter
cerebral angiogram (Figure 4C). CT angiography (CTA) and MRA
are quick non-invasive imaging modalities with good sensitivity
and specificity for large vessel abnormalities. Contrast-enhanced
MRA has a higher sensitivity and specificity for detection of verte-
brobasilar stenosis>50% as compared to CTA or ultrasound (71).
Cervical duplex ultrasound has limited ability to visualize the V1
segment and does not visualize the V4 segment. Additionally, the
density of the vertebrae precludes insonation of the portions of
the V2 segment within the transverse foramina. Insonation with
transcranial Doppler ultrasound through the foramen magnum is
able to detect velocity changes in the V4 segment consistent with
stenosis but does not routinely obtain gray scale images of the ves-
sel wall to define the cause of stenosis and is operator-dependent.
Extracranial VA dissections may be identified by Doppler color-
flow studies. Typical findings include irregular stenosis or localized
increase in vessel diameter, dissecting membrane with true and
false lumen, intramural hematoma, and tapering stenosis with dis-
tal occlusion (72). Use of contrast-enhanced MRA increases the
sensitivity for detection of dissections (73). Although MRA has
good sensitivity for vertebral dissection, it has low specificity (74)
unless combined with cervical axial T1 fat saturation sequences
which may detect crescent-shaped high intensity signal within
the pseudo-lumen suggesting intramural hematoma. CTA is supe-
rior to MRA for identifying intimal flaps, pseudoaneurysms, and
high-grade stenosis than MRI (75).
MANAGEMENT
MANAGEMENT OF VERTEBROBASILAR ATHEROSCLEROTIC DISEASE
Ideal treatment of symptomatic vertebrobasilar stenosis and indi-
cations for invasive treatments remains a topic of debate as ran-
domized controlled trials data are lacking. Patients with symp-
tomatic vertebrobasilar stenosis, defined as VA or BA stenosis
>50% by CTA or contrast-enhanced MRA have a threefold higher
90-day risk of stroke or TIA after a first event as compared to
patients without. Stroke risk is highest within the first 2 weeks and
patients with intracranial stenosis harbor an even higher risk of
early recurrence, up to 33% as compared to 16.2% for extracra-
nial stenosis (1). Management includes treatment of vascular risk
factors, statins, and antiplatelet agents similar to AC disease. Ear-
lier reports of a supraclavicular approach for endarterectomy (76)
have not been tested in a controlled manner. Bypass procedures
are technically challenging and carry a combined morbidity and
mortality of up to 17% (77, 78). Current indications for surgi-
cal intervention are few such as bypass-grafting or stenting for
subclavian steal (79) or surgical decompression for an externally
compressed vertebral artery (80). Some practitioners have adopted
the combined use of aspirin with a 90-day course of clopidogrel
after minor stroke or high-risk TIA patients based on the low stroke
rate and similar bleeding profile in the stenting and aggressive
medical management for preventing recurrent stroke in intracra-
nial stenosis (SAMMPRIS) trial (81). Additionally, a study of a
Chinese population compared aspirin monotherapy to clopido-
grel with aspirin for 90 days in patients with acute minor stroke
or TIA. This study demonstrated safety and a modest benefit of
combination therapy over aspirin (82).
In the Carotid and Vertebral Artery Transluminal Angioplasty
Study (CAVATAS), only eight patients underwent endovascular
angioplasty with or without stenting precluding meaningful con-
clusion about the utility of endovascular intervention within the
VA (83). A recent systematic review on stenting of the extracra-
nial vertebral artery showed a 1.1% 30-day peri-procedural stroke
rate, and 2-year in-stent restenosis rate of 11–30% for drug-eluting
stents and bare metal stents, respectively (84). A non-randomized
prospective single center study evaluating 114 patients from the
Borgess Medical Center vertebral artery ostium registry who
underwent ostial stenting for symptomatic vertebral stenosis of
>50% showed a 2% stroke recurrence rate at 1 year and a 25%
restenosis rate >50% irrespective of stent type used (bare metal
or drug-eluting) (24).
In the stenting of symptomatic atherosclerotic lesions in the
vertebral or intracranial arteries (SSYLVIA) trial, the 30-day peri-
operative stroke rate for intracranial stenting was 6.6% (85).
Restenosis at 6 months was reported in 35% of patients and nearly
a third were symptomatic. Intracranial angioplasty with stenting
using the Wingspan stent plus aggressive medical management
(AMM) was compared to AMM alone in the SAMMPRIS trial
(81). AMM included antithrombotic therapy with aspirin plus
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clopidogrel for 90 days, statins for target LDL ≤70 mg/dL, blood-
pressure lowering according to the seventh report of the Joint
National Committee on treatment of prevention, detection, eval-
uation, and treatment of high blood pressure, and lifestyle changes
to achieve better glycemic control, weight loss, and regular exer-
cise. Patients randomized to angioplasty with stenting had nearly
three times the rate of stroke and death at 30 days compared to the
medical arm and the trial was prematurely stopped due to the high
complication rate in the procedure arm. There were no differences
in stroke distal to the target lesion beyond 30 days up to a median
of 32.4 months between the treatment groups (86). Not only did
the angioplasty and stenting arm exceed the anticipated 30-day
stroke and death rate, the AMM only arm had fewer events than
expected (81, 86). The reasons for better-than-expected outcomes
in the latter are to date uncertain. However, the rapid reduction
in low-density lipoprotein cholesterol and blood pressure and the
potential benefits of short-term dual antiplatelet agent use may
have contributed. Only 13% of patients in SAMMPRIS had verte-
brobasilar stenosis. However, of the strokes seen within 30 days in
the angioplasty and stenting arm, most occurred at the time of the
procedure and the majority of those were due to BA paramedian
branch occlusions (87).
MANAGEMENT OF VERTEBROBASILAR DOLICHOECTASIA
Specific guidelines for treatment of VBD are lacking. Management
is typically conservative with use of antiplatelet agents or antico-
agulants. However, antithrombotic use may be associated with an
increased risk of intracerebral hemorrhage (88). Ventriculoperi-
toneal shunting for hydrocephalus, microsurgery for cranial nerve
compressions, and superficial temporal artery–superior cerebellar
artery bypass have been reported (30).
MANAGEMENT OF CARDIOEMBOLIC PC STROKE
Patients with PC stroke and atrial fibrillation should be managed
with long-term anticoagulation. Available oral agents include vit-
amin K antagonist therapy with warfarin (target INR 2.5; range
2–3), direct thrombin inhibitors such as dabigatran, and factor
Xa inhibitors such as apixaban, edoxaban, and rivaroxaban (89).
Patients with metallic prosthetic cardiac valves should receive war-
farin. Optimal antithrombotic treatment for patients with other
cardioembolic predisposing factors is at present uncertain and
needs to be individually tailored. A detailed discussion of this
topic is beyond the scope of this review.
MANAGEMENT OF ACUTE PC STROKE
Acute treatment options for PC stroke include IV recombinant
tissue-plasminogen activator (IV-rt-PA), intra-arterial fibrinoly-
sis, and endovascular thrombectomy. The acute management of
ischemic stroke is primarily governed by time from last known well
and comorbid conditions. Within the therapeutic treatment win-
dow, stroke severity based on the NIHSS play an important role
in decision-making. However, this measure has limitations in PC
stroke. Higher points in AC stroke are seen with cortical findings
and motor deficits, in contrast to fewer points assigned to cranial
nerve deficits and ataxia which may occur without weakness in PC
strokes (64, 90). Patients with PC strokes may have an unfavorable
3-month outcome despite relatively low NIHSS scores (90).
INTRAVENOUS THROMBOLYSIS
Only 5% of the National Institute of Neurological Disorders and
Stroke (NINDS) Study that led to U.S. Food and Drug Administra-
tion approval of alteplase for acute ischemic stroke had PC stroke
(91) and data regarding PC strokes in the European Cooperative
Acute Stroke Study III (ECASIII) was lacking. Clinical practice
guidelines in the U.S and Europe recommend IV-tPA as first-line
therapy for patients with ischemic stroke within 4.5 h of last known
well (92). The Third International Stroke Trial (IST 3) showed that
treatment with IV-tPA within 6 h of symptom onset was associated
with improvements in functional outcome and quality of life with-
out effect on overall survival rate (93). However, only 246 of 3025
(8.1%) randomized patients had PC strokes. Studies evaluating
the effectiveness of other IV fibrinolytics including tenecteplase
and desmoteplase with potentially longer treatment windows are
ongoing (94, 95).
Basilar artery occlusion (BAO) is a neurological emergency that
carries >80% fatality rate without treatment (96, 97) prompt-
ing heroic efforts beyond the IV thrombolytic time constraints.
BAO has variable presentation depending on the collateral flow
and individual ischemic tolerance. A study of patients treated
with IV-thrombolysis followed by full dose heparin showed that
recanalization of BAO up to 48 h from symptom onset produced
good outcomes in 50% of patients independent of time to treat-
ment (98). A Japanese study reported the outcomes of 25 patients
with BAO treated with low dose IV-rt-PA (0.6 mg/kg). Recanaliza-
tion during hospitalization occurred in 78% of patients and 44% of
patients were independent at 3 months. These patients had lower
NIHSS scores at baseline, shorter onset-to-treatment times, and
greater frequency of thromboembolic stroke etiology which may
have accounted for the more favorable results compared to other
reports (99).
INTRA-ARTERIAL FIBRINOLYSIS
The use of intra-arterial (IA) thrombolytics in PC stroke has
been previously studied (96, 97, 100, 101). Favorable outcomes
including improved survival after IA-thrombolysis for patients
with stroke due to BA occlusion has been associated with angio-
graphic evidence of recanalization (100). The recanalization rate
of occlusions in the vertebrobasilar system from IA therapy alone
is approximately 63% (102). An analysis of 420 non-randomized
patients with BAO treated with IA-thrombolysis (82%) or IV-
rt-PA (18%) showed IA-thrombolysis more frequently achieved
recanalization than IV-rt-PA (65 vs. 53%). However, death or
dependency and favorable functional outcomes were not signifi-
cantly different. Regardless of treatment modality, a good outcome
was achieved in only 2% of those without recanalization, under-
scoring the devastating nature of BAO and importance of BA
recanalization (96). Establishing the ideal treatment modality for
BAO has been challenging. An early randomized controlled trial
of IA thrombolytic infusion in patients with BA occlusion was too
small to demonstrate meaningful conclusions (97). The Basilar
Artery International Cooperation Study (BASICS) prospectively
observed and compared outcomes of patients with BAO and
found no conclusive evidence of superiority for IA-thrombolysis
over IV-thrombolysis and prompted the need for a randomized
control trial (103). The American Heart Association/American
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Stroke Association recommends IA-rt-PA in select patients with
MCA occlusion within 6 h of symptom onset but no recommen-
dation is made for IA-thrombolysis in PC stroke including BA
occlusion (104).
MECHANICAL THROMBECTOMY
Recanalization has a strong association with clinical outcome. A
large meta-analysis of 53 studies with reported recanalization rates
including 2066 patients demonstrated a four- to fivefold increase
in the odds of a good functional outcome and similar decrease in
the odds of death in patients with successful recanalization (102).
In addition, patients with partial or complete early recanalization
fare better than those with delayed recanalization or persistent
occlusions (105–107). Mechanical thrombectomy achieves high
recanalization rates for all target vessels in reported device trials.
Recanalization is more readily achieved with the stent retrievers
than older generation devices such as coil retrievers and aspira-
tion catheters (108) though data on patients with PC stroke is
limited. Only 10% of strokes included in the Merci trial were in
the PC with 50% success achieving partial or complete recanal-
ization (105). In the Multi-Merci trial, 8.5% of patients had PC
stroke with an 86% successful recanalization rate (109) and 9%
in the Penumbra Pivotal study with no specific data regarding PC
recanalization (107).
Recent randomized controlled trials have not clarified the role
of endovascular therapy for acute ischemic stroke in general and
PC stroke in particular. The interventional management of stroke
III (IMS III) trial, showed no overall benefit of endovascular rescue
therapy after IV-rt-PA compared to IV-rt-PA alone in 656 ran-
domized patients with ischemic stroke and NIHSS≥10. However,
older generation thrombectomy devices were employed, onset-
to-treatment times were long, and only 2% of patients had PC
stroke. A favorable trend was seen for patients receiving IV-rt-PA
within 2 h of symptom and endovascular rescue therapy within
90 min of IV-rt-PA initiation (110). The SYNTHESIS expansion
trial randomized patients with ischemic stroke to IV-rt-PA or IA-
thrombolysis with optional mechanical thrombectomy. Overall,
endovascular treatment was not found to be superior to IV-tPA
alone, few patients received mechanical thrombectomy and only
8% of randomized subjects had PC stroke (111). PC strokes were
systematically excluded from the magnetic resonance and recanal-
ization of stroke clots using embolectomy (MR RESCUE) trial
evaluated endovascular therapy which concluded that a favor-
able penumbral pattern on neuroimaging was not able to identify
patients who would differentially benefit from endovascular ther-
apy for acute ischemic stroke in the AC within 8 h (112). Multiple
critiques following these publications have raised issues with study
design, infrequent use of newer devices, patient selection, and dos-
ing of IV thrombolytic among others. Despite these criticisms and
the fact that PC strokes were under-represented, the conclusions
from these studies have thus far been discouraging (113).
MANAGEMENT OF VERTEBROBASILAR DISSECTIONS
The main mechanism of stroke after cervical arterial dissection is
thromboembolism rather than hemodynamic compromise. This
prompts consideration regarding antithrombotic selection for
recurrent stroke prevention (36). Antithrombotic agents including
anticoagulants or antiplatelet agents are typically employed. The
use of either therapy may depend on stroke severity, infarct size,
bleeding risk, the presence of free floating thrombus, or intracra-
nial extension of the dissection. When anticoagulation is chosen,
a short period of 3–6 months is usually employed (114). The
majority of dissection heal within 2–3 months with >90% res-
olution of stenosis (36). Typically, intracranial extension of a
dissection carries a higher risk of subarachnoid hemorrhage and
anticoagulation is not recommended. The only randomized con-
trolled trial evaluating the effectiveness of antiplatelet therapy
compared to anticoagulation for patients with acute cervical arte-
rial dissections is currently underway (115). In patients with acute
occlusion or dissecting aneurysms, stent-assisted coil emboliza-
tion or double stent placements may be an alternative treatment
(116).
POST STROKE CONSIDERATIONS FOR THE POSTERIOR FOSSA
Cerebellar infarctions can rapidly swell due to cytotoxic edema
within the tight constraints of the non-yielding posterior fossa and
lead to obstructive hydrocephalus or fatal herniation if not ade-
quately managed in a timely fashion (117–119) (Figures 4D–F).
Patients should be clinically monitored for signs of increased
intracranial pressure such as headache, vomiting, lethargy, dis-
orientation, or neurologic deterioration, as well as evidence of
hypertension, bradycardia, or irregular respiratory pattern. Acute
temporizing measures would include hyperventilation,head eleva-
tion to 30°,osmotherapy,blood-pressure management to maintain
cerebral perfusion, and sedation until definitive surgical treat-
ment is started (120). Patients who receive surgical treatment
fare better than those only medically managed, with better func-
tional outcomes and lower mortality (119). Unilateral cerebellar
infarctions may be managed with ventriculostomy, suboccipital
decompression with or without removal of necrotic tissue, or a
combination of all three. In a study of patients with unilateral cere-
bellar infarctions with a median Glasgow Coma Scale (GCS) of 9
that received all three surgical treatments, GCS scores improved
to 13.6 at discharge and mortality was 31% (118). In patients with
malignant cerebellar edema, bilateral suboccipital decompressive
craniectomy has been shown to be safe with a 6-month mortality
of 28% (117).
CONCLUSION
Several anatomical and clinical differences distinguish PC infarc-
tions from those in the AC and have practical implications. Vas-
cular anatomical variation may affect stroke severity and present-
ing signs and symptoms. Large vessel atherostenosis is common
but cardioembolic strokes, dissections, and other etiologies are
known to affect the PC. Quantitative measures such as the NIHSS
alone may not suffice and clinical signs and symptoms such as
dizziness, vertigo, and ataxia may be diagnostic pitfalls. MRI is
superior to CT for imaging an acute PC infarct but may rarely
miss a small infarct early on. A variety of non-invasive vascu-
lar imaging modalities are available to aid the etiologic work-up
and have replaced conventional catheter angiography in many
circumstances. IV-rt-PA is the recommended first-line treatment
for eligible patients. The role of endovascular acute revascular-
ization therapy remains uncertain at present. The cornerstone
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of recurrent stroke prevention includes risk factor control pri-
marily blood-pressure lowering, lipid-lowering with statins, and
antithrombotic therapy. Aggressive medical management has been
shown to be superior to endovascular angioplasty and stenting
in patients with a range of intracranial atherostenosis including
lesions in the PC.
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